Aurinia Pharmaceuticals Inc. (AUPH) — 8-K Filings

8-K Filings (6)

• Aurinia Pharmaceuticals Files 8-K — Jun 30, 2025 Risk: low
  Aurinia Pharmaceuticals Inc. filed an 8-K on June 30, 2025, to report other events. The filing does not contain specific details about the nature of these event
• Aurinia Pharmaceuticals Inc. Files 8-K on Corporate Governance Changes — May 15, 2025 Risk: low
  Aurinia Pharmaceuticals Inc. filed an 8-K on May 15, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of ce
• Aurinia Pharmaceuticals Relocates Principal Offices — Sep 12, 2024 Risk: low
  Aurinia Pharmaceuticals Inc. announced on September 9, 2024, a change in its principal executive offices to #140, 14315 - 118 Avenue, Edmonton, Alberta T5L 4S6.
• Aurinia Pharmaceuticals Files 8-K for Shareholder Votes & Financials — Jun 14, 2024 Risk: low
  Aurinia Pharmaceuticals Inc. filed an 8-K on June 14, 2024, to report on matters submitted to a vote of security holders and financial statements. The filing do
• Aurinia Pharma Reports Officer/Director Changes & Compensation Arrangements — Feb 29, 2024 Risk: medium
  Aurinia Pharmaceuticals Inc. filed an 8-K on February 29, 2024, reporting an event that occurred on February 27, 2024. The filing pertains to Item 5.02, specifi
• Aurinia Pharma Files 8-K on Operations & Financial Condition — Jan 5, 2024
  Aurinia Pharmaceuticals Inc. filed an 8-K on January 5, 2024, reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibit

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX